Log In
Print
BCIQ
Print
Print this Print this
 

sotagliflozin (LX4211 tablet)

  Manage Alerts
Collapse Summary General Information
Company Lexicon Pharmaceuticals Inc.
DescriptionDual sodium-glucose cotransporter 1 (SGLT1) and SGLT2 inhibitor
Molecular Target Sodium-glucose cotransporter 1 (SGLT1) ; Sodium-glucose cotransporter 2 (SGLT2)
Mechanism of ActionSodium-glucose cotransporter 2 (SGLT2) inhibitor; Sodium-glucose cotransporter 1 (SGLT1) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationDiabetes
Indication DetailsTreat Type I diabetes; Treat Type II diabetes
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today